1. health and fitness
2. disease
3. cancer

Chinese herbal medicine in the treatment of lung cancer / Asian Journal of Traditional Medicines, 2008, 3 ( 1 )
Review
Chinese herbal medicine in the treatment of lung cancer
Yang Zhou, Wenyuan Gao *, Kefeng Li
School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, 92 Weijin Road,
Tianjin 300072, China
Abstract
Chinese herbal medicine has been the traditional treatment for numerous human diseases for thousands of years. It has performed
well clinically and, for this discussion, it has shown great promise for the treatment of many symptoms which modern medicine
has associated for centuries with lung cancer. Many medicinal plants have been tested for anticancer activity such as antofine,
acutiaporberine, etc. The compounds which have been isolated from these medicinal herbs include a variety of alkaloids,
triterpenoids, flavonoids, terpenoids, and polysaccharides. Some of the formulas used in clinical tests have been combined with
chemotherapy. Traditional Chinese Medicine (TCM) formulae such as shenyi capsule and aidi injection contain numerous
ingredients so that they may be considered to have anit-lung cancer activity as well as serving as immunomodulators. They have been
demonstrated to ameliorate or prevent adverse effects as a result of the use of single drugs. Research on Chinese herbal medicine for
the treatment of lung cancer has not only been shown to aeffect lung cancer, but to also provide important methods for the study of
lung cancer therapy. This report reviews some of the findings resulting from the use of Chinese herbal medicine in the treatment of
lung cancer.
Key words: lung cancer; Chinese herbal medicine; medicinal plants; traditional Chinese formulae
cancer: (1) squamous cell (epidermoid) carcinoma, (2)
small-cell (oat cell) carcinoma, (3) adenocarcinoma,
and (4) large cell carcinoma. Based on its biology,
therapy, and prognosis, lung cancer is divided into two
major classes: non-small cell lung cancer (NSCLC)
and small cell lung cancer (SCLC) [2]. Non-small
cell lung cancer accounts for 75 % to 80 % of all lung
cancer cases. Small cell lung cancer (SCLC) accounts
for 15 % to 25 % of all lung cancer. About 98 % of
SCLC is attributed to cigarette smoking [3 -5].
Conventional treatment of either form of lung
cancer is fairly ineffective.
Therefore, attention has been paid to natural, active
substances. To date, many of the chemotherapeutic
agents are medicinal plants or are derived from
medicinal plants. Interestingly, herbs have been used
in the treatment of various cancers for a long period of
time and their therapeutic effects involving anticancer
Lung cancer is the leading cause of cancer death
among both men and women. There will be an
estimated 162, 460 deaths caused by lung cancer (90,
330 among men and 72, 130 among women) in 2006,
accounting for around 28 % of all cancer deaths. More
people die of lung cancer than from colon, breast, and
prostate cancers [1]. As classified by the World Health
Organization, there are four major types of lung
* Author to whom correspondence should be addressed. Address:
Traditional Chinese Medicine and Natural Products Department, School
of Pharmaceutical Science and Biotechnology, Tianjin University,
300072 Tianjin, China; Tel: +86-22-87401895; Fax: +86-22-87401895;
E-mail: [email protected]
This paper was funded by the Tianjin application of basic research
projects. (Title: The research of the Chinese medicine Saponin-floor’
s major component anti-cancer compatibility and efficiency. Project
number: 07JCZDJC05400)
Received: 2007-05-16
Accepted: 2007-10-10
Chinese herbal medicine in the treatment of lung cancer / Asian Journal of Traditional Medicines, 2008, 3 ( 1 )
under the categories describing "lung-masses",
"expanding-masses", "cough", "cough blood" and
"chest pain". Several ancient medical books make
reference to it. For example, in "Summary from the
Golden Chest” (Han Dynasty 206-220AD) under the
five organs section, it states "the [lung] mass cannot be
easily removed." In the Huang Di Nei Jing Su Wen,
another famous book written during the Han dynasty,
it refers to "difficult breathing [with lung cancer]
without having difficult eating." TCM believes that
lung cancer results from having a lack of healthy
energy and from the accumulation of exogenous evils
(outside influences that invade the body and cause
illness). Lung cancer can be divided into 5 different
syndromes including: 1. Yin Deficiency and Interior
Heat Syndrome (The symptoms here include a cough
without sputum or a cough with thick sputum). 2.
Spleen Deficiency and Phlegm Dampness Syndrome
(These symptoms include a cough that produces a
great deal of sputum and chest tightness accompanied
by shortness of breath.). 3. Deficiency of Qi and Yin
Syndrome (These symptoms include a low and weak
sounding cough, which produces a small amount of
sputum which can be bloodstained). 4. Deficiency
of Yin and Yang Syndrome. 5. Stagnation of Qi and
Blood Stasis Syndrome [9].
Approximately 133 Chinese herbal medicines
have been reported to possess anti-lung cancer effects.
They are categorized into the five subgroups listed
below [10].
properties have been scientifically evaluated both in
vitro and in vivo. Herbal medicine, recorded in many
countries (e.g., Chinese Pharmacopoeia), has been
prescribed for lung cancer over centuries and has
begun to draw increasing scientific attention. Based
on recent scientific research on herbs, herbal therapies
have been considered alternative treatment for some
malignancies [6-7]. Various components in herbs may
have synergistic activities or buffer toxic effects
of other components. In addition, extracts from a
mixture of herbs may have more therapeutic or cancerpreventive activities than a herb alone. Several studies
have demonstrated that extracts from some herbal
medicines or their mixtures have anticancer potential
and can inhibit cancer cell proliferation in vitro and/or
in vivo [8].
Since CHM has performed well clinically and
has shown promise for the treatment of several lung
cancer symptoms, it has attracted the interest of many
investigators. A number of TCM formulae have
synergistic effects due to multiple ingredients which
inhibit lung cancer at different stages, strengthen
impaired immune system function, and improve the
overall symptomatology. In addition, they have been
demonstrated to ameliorate or prevent adverse side
effects associated with the use of single drugs. Many
studies reported that many TCM treatments increase
the body's resistance to invading pathogens infectious
agents that cause disease which can lead to an increase
in a patient's lifespan. These treatments can also
help some patients who can not accept surgery or
radiotherapy.
The purpose of this review is to present those
medicinal herbal extracts and compounds which have
been tested for activity against lung cancer in vitro.
Specifically, the Traditional Chinese formulae that
have been tested in laboratory and clinical studies for
the treatment of lung cancer will be discussed.
Clearing heat and toxins
Herba Hedyotis Diffusae, Herba Scutellariae
Barbatae, Herba Houttuyniae, Herba Solani Nigri,
Fructus Bruceae, Rhizoma Paridis, Pseudobulbus
Cremas-trae Seu Pleiones, Herba Selaginella
Doederleinii, Herba Salviae Chinensis, Spica
Prunellae, Radix Trichosanthis, Radix Rehmanniae,
folium Rabdosiae Rubescentis, Radix Codonopsis,
and Vene-num Bufonis．
Classification of CHM for lung cancer
According to TCM theory, lung cancer is included
Resolving dampness and phlegm semen
Chinese herbal medicine in the treatment of lung cancer / Asian Journal of Traditional Medicines, 2008, 3 ( 1 )
in vitro and that a number of active plant-derived
compounds are from various chemical classes such
as akaloids, triterpenoids, flavonoids, terpenoids and
polysaccharides.
Coicis，Polyporus, Radix Stephaniae Tetran-drae,
Fructus Trichosanthis, Radix Stemonae, Rhizoma
Pinelliae, Bulbus Fritillariae Thunbergii, Sargassum,
Thallus Laminariae or Thallus Eck-loniae, Rhizoma
Arisaematis, and Semen Lepidii or Semen De
scurainiae．
Alkaloids
Solamargine (SM) [11] is an alkaloid isolated from
an herb, Solanum incanum. It was found to be a
powerful cytotoxic agent in four human lung cancer
cell lines. Half-inhibitory concentration (IC50) is the
concentration of a compound needed to reduce growth
of a population of cells by 50 percent in vitro. SM had
IC50 value for the lung cancer cell lines, IC50 = 500 ng/
ml. H441, H520, H661 and H69, of 3, 6.7, 7.2 and 5.8
µM, respectively. SM-induced apoptosis of these cells
determines by PS (PS: phosphatidylserine, turmor
necrosis factor receptor) externalization in a dosedependent maner and increased the percentage of cells
in the sub-G1 fraction of the cell cycle. SM treatment
was found to increase the binding activities of TNFalpha and TNF-beta to lung cancer cells. Then the
cell lines that were intrinsically TNF-resistant became
susceptible to both TNF-alpha and -beta. In addition,
SM induced several apoptotic processes: release of
cytochrome C from mitochondria, downregulation of
anti-apoptotic Bcl-2 and Bcl-xL, increase of caspase-3
activity, and DNA fragmentation. Thus, SM can
induce apoptosis and modulate expression of TNFRs
and Bcl-2. Therefore, SM is a potential anticancer
agent for human lung cancers that display TNF- and
Bcl-2-related resistance.
Nitidine [12-13], a natural topoisomerase poison,
is the well-known benzophenanthridine alkaloid
found in the root of Zanthoxylum nitidum (Roxb.)
DC (Rutaceae). In experimental studies, nitidine
exhibited antitumor activity against LLC (lewis lung
carcinoma). It is a DNA intercalator that is generally
classified as an inhibitor of topoisomerases I and II.
A quaternary phenanthridinium alkaloid，
lycobetaine, from Lycoris radiata (Amaryllidaceae),
was reported to be antineoplastic [14]. At growth-
Regulating Blood and Qi
Rhizoma Curcumae, Radix Notoginseng, Semen
Vaceariae, Radix Paeoniae Rubra, Semen Persicae,
Herba Agn-moniae, Fructus Akebiae, and Pericarpium
Citri Reticulatae．
Reinforcing Qi
Radix Astragali, Radix Ginseng, Radix Codonopsis,
Herba Gynostemma-tis, and Cordyceps．
Nourishing Yin
Bulbus Lilii., Radix Glehniae，Radix Adenophorae，
Radix Ophiopogo-nis，Radix Asparagi，and Plastrum
Testudinis．
Laboratory studies
In vitro studies
The majority of laboratory studies of anticancer
activities in lung cancer investigated individual CHMs.
and a few have also studied immunomodulation
effects. These studies have been undertaken
in established animal models, such as Lewis
lung carcinoma, and in human lung cancer cell
lines. Based on the large body of chemical and
pharmacological research, some bioactive compounds
isolated from medicinal plants have been used
to treat lung cancer. Each herbal medicine has
specific chemical constituents which have different
pharmacological and toxicological profiles. A variety
of chemical constituents isolated from medicinal
herbs have been studied extensively and tested for
anticancer activity. The date compiled in Table 1
revealed that extracts of plant species from a wide
range of families have significant anticancer activities
Chinese herbal medicine in the treatment of lung cancer / Asian Journal of Traditional Medicines, 2008, 3 ( 1 )
Table 1. Phytochemical components and mechanism of action of selected medicinal plants used to treat lung cancer
Plants
Plant compound
Cell line affected
Mechanism of apoptosis
Angelica sinensis
Acetone extract
A549 HT29
J5DBTRG-05MG
Activation of caspase 9 3 mediated via the suppression of
Bcl-2 and cdk 4 expression. No activation of caspase-8.
Bupleurum falcatum
Saikosaponin D
A549
Increasing the expression of p53 and p21/WAF1proteins
and induction of Fas/APO1.
Bupleurum scorzonerifli-um
Acetone extract
A549
Inhibited telomerase activity.
Coxi lachryma
Methanolic
extract
A549
Inhibition of cyclin A expression and activation via
caspase cascade.
Curcuma longa
Curcumin
A549 HT1299
Decreased expression of p53, bcl-2, bcl-XL.
Lithospermum radix
­HIVS
DMS114
Decreased and suppressed the expression of
TRAP1.
Thalictrum acutifolium
Acutiaporberine
95-D, PLA-801
Inhibited expression of bcl-2 gene and activated
expression of bax gene, p53 independent.
Solanum incanum
Solamargine
A549
Increased the release of cytochrome c.
Decreased the bcl-2 and bcl-XL. Increased Bax and
caspase-3 activity
Scutellaria barbata
Ethanol extract
A549
Activation through caspase cascade. Increase caspase
3/7. Activation of cell cycle control genes such as
STK6, MCM5, etc.
Plant pigments
Acacetin
A549
Via p53 pathway
Liliaceae plants
Isoliquiritigenin
A549
Via p53 pathway
Grapes peanuts pines and
other Leguminosae family
Xanthium strumarium L
Stilbenoids
A549
Via p53 pathway
8-epi-xanthatin
A549
Inhibited microtuble interfering
Lycoris radiata
(Amaryllida-ceae)
Zanthoxylum nitidum
(Roxb.) DC (Rutaceae)
Indigofera tinctoria
Lycobetaine
LXFL 529
Inhibited topoisomerase I and II
nitidine
LLC
Inhibited topoisomerase I and II
Indirubin
LLC
Inhibited DNA polymerse I
Hedera colchica K. Koch
A549
Inhibited DNA synthesis
Hedera helix
Hederacolchicoside A1
beta-hederin
A549
Inhibited DNA synthesis
Nigella sativa L. seeds
alpha-Hederin
P388
Inhibited DNA, RNA, protein synthesis in a dose-and
time-dependent manner
Physocarpus intermedius
Schn. (Rosaceae)
ursolic acid
A549
Inhibited DNA synthesis
Cynanchum paniculatum
Kitagawa
Antofine
A549
Inhibited protein synthesis
Scutellaria baicalensis
Georgi
Baicalein
LXFL 529L
Inhibited 12-lipoxygenase
N.B. reference is given in the text.
Chinese herbal medicine in the treatment of lung cancer / Asian Journal of Traditional Medicines, 2008, 3 ( 1 )
responsible for much of the color in nature [19]. They
are potent antioxidants that occur naturally in foods and
they can inhibit carcinogenesis in rodents. Acacetin
(5, 7-dihydroxy-4’-methoxyflavone), a flavonoid
compound, has been reported to possess antiperoxidative, anti-inflammatory and antiplasmodial
effects [20]. It was reported that acacetin can inhibit
A549 cell proliferation in a dose-dependent manner.
Its IC 50 value was 9.46 μM. The proliferation
inhibitory effect of acacetin was observed to be in a
dose dependent manner with A549 human lung cancer
cell lines. Its IC50 value was 9.46 μM. The effect of
acacetin on cell cycle progression of A549 with 5 μM
increased the population of the G1 phase from 34.7 %
to 42.6 %. DNA fragmentation of A549 was found at
12 hours and maximized at 48 hours after exposure of
A549 cells to acacetin with 5 and 10 μM. In addition,
it was found that acacetin increased the expression of
p53 and p21/WAF1 proteins in A549 cells [21].
Quercetin, another flavonoid, can induce the
interaction of nuclear factor-kappaB (NF-KB)
and hypoxia inducible factor 1α (HIF-1α) in lung
adenocarcinoma LA795 in mice, in combination
with DDP (diamminedichloroplatinum). Thirty two
T739 mice bearing metastatses of LA795 cells were
randomized into four groups: a control group, a DDP
group, quercetin group and quercetin +DDP group.
After 24 days, tumor weight and the tumor growth
inhibition rate were determined. The number of lung
metastases, and the metastatic foci inhibitory rate
were determined. In addition, the comparative NFKB and HIF-1a levels in subcutaneous tumors were
determined by an immunohistochemical method. The
results indicated that quercetin and its combination
with DDP resulted in a significant inhibition in
the growth of LA795 cells in vivo (P<0.05). The
combination group indicated that there was a potent
synergetic effect between the two agents in decreasing
metastatic foci on the lung surface. The mechanism
may be due to the suppression of the expression of
NF-KB and HIF-1α [22].
inhibitory concentrations, lycobetaine inhibited
topoisomerases I and II, stabilized the covalent DNA
topoisomerase I intermediate (the so-called cleavable
complex), and induced apoptosis.
Triterpenoids
Hederacolchicoside A1，an oleanolic acid
monodesmoside ，is isolated from Hedera colchica
K. Koch (Araliaceae) and beta-hederin (another
monodesmoside oleanolic acid, isolated from Hedera
helix and other species) have demonstrated effective
cytotoxicity against A549, a human lung cancer cell
line, with similar IC50 of about 10 mM (cisplatin,
the positive control tallied 5 mM). Unfortunately, it
was found to affect both cancerous as well as normal
cells as similar cytotoxicity was observed for human
fibroblasts [15].
Kim et al. found that seven triterpenes isolated
from the stem bark of Physocarpus intermedius Schn.
(Rosaceae). Of these, 3-O-caffeoyloleanolic acid,
betulinic acid, and the methyl ester of euscaphic acid
(in order of decreasing potency) were the most active
in vitro against A549 cells, ED50 (median effective
dose) values of 1.6, 2.0, and 3.7 mg/ml, respectively,
whereas the ED 50 for cisplatin was 11.4 mg/ml.
Since ursolic acid was found in a relatively higher
concentration in the extract, the authors hypothesized
this compound is responsible for the strong
cytotoxicity of the extract. Its ED50 was determined to
be 4.2 mg/ml against A549 cells [16].
Saikosaponin D, one of the major components of
Bupleurum falcatum, which can also be extracted from
other species of Bupleurum and from related genuses,
has been used for the treatment of various liver
diseases for a long time in China [17]. It can inhibit
the proliferation A549 cell line, with an IC50 value of
10.18 +/- 0.09 μM [18].
Flavonoids
Flavonoids，a broadly distributed class of plant
pigments, universally exist in vascular plants and are
Chinese herbal medicine in the treatment of lung cancer / Asian Journal of Traditional Medicines, 2008, 3 ( 1 )
certain cancer cells in vitro. PSP in dose-dependent
and time-dependent manners suppresses proliferation
of human cancer cell lines [9]. PSP markedly inhibited
the growth of several human cancer cell lines
including lung cancer cell lines in vitro [26]. Significant
reductions in tumor size occurred after prolonged
administration of PSP in mice inoculated with Lewis
lung carcinoma. Since there is a lack of clinical trials
on the efficacy of PSP in lung cancer treatment, a
clinical study was conducted by Dr. Kenneth Tsang
at the University of Hong Kong's School of Medicine
in 1999 on the effect of PSP treatment in patients
with advanced non-small cell lung cancer. This study
suggested that PSP treatment may be of some benefit
in these patients [27-28].
Baicalein, wogonin, their glucopyranosiduronides
baicalin and wogonoside, and skullcapflavone II
(neobaicalein) are flavonoids isolated from the root
of Scutellaria baicalensis Georgi (Lamiaceae). They
all inhibited the growth of the human tumor cell
lines, LXFL and 529L (large cell lung carcinomas) at
micromolar rconcentrations. In many forms of cancer,
baicalein acts by inhibiting 12-lipoxygenase activity
[23]
.
Terpenoids
A study reported that 8-epi-xanthatin and its
epoxide, two xanthanolide sesquiterpene lactones
from the methanolic extract of the leaves of
Xanthium strumarium L. (Asteraceae), potently
inhibited proliferation of cultured human tumor cells,
including A549 cells. Their IC 50 values were 4.5
and 3.0 µM, respectively, while cisplatin, used as a
positive control, had an IC50 of 4.7 mM [24]. At higher
concentrations (64 and 58 mM, respectively) the two
xantholides showed a promising farnesyltransferase
(FTase) inhibitory effect. Synthetic FTase inhibitors
have demonstrated activity against various human
cancer cell lines, including NSCLC [28]. An earlier
study demonstrated that X. strumarium extracts are
able to effectively inhibit tubuline polymerization in
mammalian tissues [25], which could be a plausible
mechanism for these findings.
Other extracts from CHM with anticancer
potential
Coxi lachryma (or Adlay seed) has long been used
not only in TCM, but also as a nourishing food. The
methanolic extract of the Adlay seed was tested and
found that it inhibited the proliferation of A549 cells
in a dose-dependent manner with an IC55-IC65 of 100
μg/ml. It (300 μg/ml) also induces time-dependent
degradation of PARP from 116 kDa to 85 kDa during
treatment of A549 cells [29].
The root of Angelica sinensis, also known as
“Dang Gui”, is a popular herbal medicine and has been
widely used in China for gynecological diseases for
some time. Bio-based assay for extracts of Angelica
sinensis showed that the acetone extract (AE-AS)
induced dose-dependent antiproliferative effects in
A549, HT29, DBTRG-05MG and J5 human cancer
cells. The IC50 values of AE-AS in these cell lines
ranged from 35-50 μg/ml after 24 h of treatment [30].
Indirubin (isoindigotin, indigo red), named
Qing Dai in TCM, has been effectively used as an
antileukemic agent. It is a bisindole derivative and
the red-color isomer of indigo. It is isolated from
Indigofera tinctoria (Fabaceae). Indirubin can also
be extracted from the leaves of Baphicacanthus cusia
(Acanthaceae), Polygonum tinctorium (Polygonaceae),
Polysaccharides
Coriolus vesicolor is also known as Yun Zhi or
"cloud mushroom" in Chinese. TCM practitioners
of centuries ago understood that this mushroom
has special health properties which seem to be
useful for maintaining general health and delaying
normal aging processes if taken appropriately [9].
Polysaccharopeptide (PSP) is the active ingredient
of Yun Zhi responsible for its health benefits. PSP
has been shown to manifest immunomodulatory and
anticancer properties in both pre-clinical experiments
and in clinical trials. Several studies reported that
PSP possesses selective anti-cancer activity against
Chinese herbal medicine in the treatment of lung cancer / Asian Journal of Traditional Medicines, 2008, 3 ( 1 )
Isatis indigotica (Brassicaceae), and Indigofera
suffrutticosa (Fabaceae) [26]. Indirubin inhibits LLC
in mice. It exerts its anticancer effects by inhibiting
DNA polymerase I activity and therefore, DNA
synthesis. It inhibited DNA synthesis in several cell
lines, in a cell-free assay, and in vivo in rats with
Walker-256 sarcoma [19, 31].
In another study it was found that two types
of Chinese traditional herbs, Rhizoma curcumate
zedoariae and Herbra trifolii repentis acted
synergistically and in a dose-dependent manner to
induce more A549 cell apoptosis than treatment with
either agent alone (P<0.01) [32].
The effects of Yi Qi Huo Xue (YQHX) on
human cancer cell lines, A549 and small cell lung
cancer (NC-H446), were studied in vitro. Several
methods were used to exam cell proliferation and
migration, including cytometry, imunohistochemistry,
imaging techniques, a Boyden chamber method
and expression of E-CD for cell migration. The
quantity of two strains of cells crossed Matrigel
and polyvinylpyrrolidone-free polycarbonate filter
were significantly more than the controlled group
(P<0.01). YQHX inhibited the proliferation of A549
or NC-H446 cells while enhancing the expression of
E-CD. In addition, it decreased migration of these
cells in vitro [34].
Sangenquliu decoction and Sansi mixture
demonstrated inhibitory effects on Lewis lung
carcinoma growth and metastasis in mice [35, 36] .
Some other formulae had anti-tumor activity due
to modulation of the host’s immune system. It is
reported that the QiJia Mixture had antitumor effects
in Lewis lung carcinoma-bearing mice and that
this was probably due to augmentation of T and B
lymphocyte activity [37].
Metastasis in advanced stages of cancer has
significant implications for prognosis and clinical
management. Studies of administering the herb
mixture Xiao Chai Hu Tang in mice suggested that it
effectively inhibited Lewis lung carcinoma growth and
metastasis and that these effects might be associated
with macrophage activation and augmentation of NK
cell activity, as well as increases in interferon activity
and interleukin-6 levels in serum [38].
Traditional formulas with anticancer
effects studied in vitro
Traditional formulas containing combinations
of herbal medicines have the potential to become
therapeutics of choice due to synergistic effects that
inhibit lung cancer at different stages, strengthen
impaired immune function and improve overall
symptomatolgy. The formulas were based on
traditional understanding, clinical experience
and knowledge of the pharmacological actions of
individual herbs.
Chinese medicinal decoction of FU ZHENG
HE JI Decoction that had been reported to have
anticancer activity against LA795 cells in mice. It
had shown the effect of reducing side effects due to
chemotherapy. Compared with the control group, the
group treated with the herbal formula decreased the
effect of IL-6, and increased the quality of TUF- a,
IL-2 (cytokines) in mice [33]. This formula contains
primarily Codonopsis (Codonopsis radix), ligustrum
(Ligustri lucidi Fructus), astragalus (Astragali
adix), Chinese angelica (Angelicae radix) and
yellow essence (Plugonati rhizoma). It significantly
promotes apoptosis of cancer cells. The formula was
shown to spleen Qi, nourish the blood, enrich Yin and
supplement the kidney at the same time quicken the
blood and transform stasis in the body [9].
Clinical studies
Human studies and potential health and
therapeutic applications
TCM may elevate the efficacy of chemotherapy.
Often the combined treatment of western medicine
and TCM produces better outcomes than using either
method alone. TCM may reduce symptoms and improve
Chinese herbal medicine in the treatment of lung cancer / Asian Journal of Traditional Medicines, 2008, 3 ( 1 )
Paridis et al. were studied in a group of 290 NSCLC
inpatients that were in a prospective prognostic sdtudy
by a cooperative group. They were divided randomly
into 4 groups: group A treated with JFK, group B
treated with chemotherapy, group C treated with JFK
plus chemotherapy. After treatment, the symptoms,
KPS score (measuring QOL) and immune parameters
(serum levels of NK, IL-2, CD3+, CD4+, CD8+) were all
improved in groups A and C, compared with those in
group B. No deleterious side effects occurred in group
A. In group B there were toxicities mainly in bone
marrow depression, decreases of blood white blood
cells, and hair loss. However, the toxicities were
lower in group C than in group B (P<0.01) [41].
Qing Re Jie Du decoction is another traditional
Chinese formula. The efficacy, side effects and
QOL of patients treated with vinorelbine (NVB) plus
cisplatin (DDP) (NP regimen) alone or combined with
the Qing Re Jie Du decoction were compared during
studies of NSCLC. A total of 72 patients (stage IIIIV) were randomly divided into an observation group
(40 patients) and a control group (32 patients)．The
efficacy rates in the observation group (52.5 %) were
significantly higher than those in the control group
(45.0 %) with a P value <0.05. In the observation
group，the scores calculated by KPS were higher
than those in the contro1 group (P<0.001)，and the
degrees of hypo1eukocytosis or platelet reduction
were lower with a P value < 0. 001) [42].
Ai Di injection, when combined with
chemotherapy, was found to be helpful in improving
clinical symptoms and the QOL in patients with
medium to advanced lung cancer. Seventy two patients
were enrolled in a study and divided randomly into
two groups. Thirty-seven patients received Ai Di
injection in combination with chemotherapy (the
study group), and 35 patients received chemotherapy
alone (the control group). The response rates in the
study group and control group were 51.4 % and 54.3 %,
respectively. However, the clinical symptoms and QOL
were significantly different between the two groups, P =
physical performance and clinical efficacy [9]. It should
be mentioned that the combinations of chemotherapy and
Chinese medicine and herbal products are commonly
used by patients [39].
To evaluate the effect of Chinese herb medicine
Wei Mai Ning on the quality of life (QOL) and
immune function of patients with advanced lung
cancer, 63 patients with advanced lung cancer and
prognoses of more than 3 months survival underwent
3 cycles of treatment. The QOL in the chemotherapy
plus Wei Mai Ning group improved significantly
compared with the group treated with chemotherapy
alone (P<0.01). The clinical benefis were evaluated
using Karnofsky Performance Status (KPS) scores.
The KPS score is a system that evaluates changes of
physical fitness of patients and changes in body mass.
The stability rate of KPS scores and of body mass
in the chemotherapy plus Wei Mai Ning group were
significantly higher (65 % and 38 %, P<0.05) than
those of the group treated with chemotherapy alone
(68 % and 34 %, P<0.01). The toxicity response was
evaluated according to the classification of the World
Health Organization (WHO) criteria (0-IV rating).
The white cell number was reduced and nausea and
vomiting were more serious in the group treated with
chemotherapy alone compared with the group treated
with chemotherapy plus Wei Mai Ning (P<0.05
and P<0.01. Treatment with the combination did
not induce any serious toxicity. Clinical symptoms
such as cough and shortness of breath in both groups
were released. In addition, the number of T cells in
the group treated with three cycles of chemotherapy
plus Wei Mai Ning was increased compared with
the number present prior to treatment (after, (2.23±
0.7)，before, (1.90±0.6), P<0.051). So Wei Mai Ning
combined with chemotherapy yields low toxicity and
significantly improves the QOL and immune function
of patients with advanced lung cancer [40].
Treatment with Jin Fu Kang Oral Liquid
compounded with Radix Astragali, Radix Glehnine,
Radix Ssparagi, Fructus Liqustri Lucidi, Rhizoma
Chinese herbal medicine in the treatment of lung cancer / Asian Journal of Traditional Medicines, 2008, 3 ( 1 )
0. 035 in the study group and 0.019 in the control. Ai Di
is prepared primarily from ginseng (Ginseng radix),
astragalus (Astragali radix), mylabris (Mylabris), and
Acanthopanax senticosus. This preparation has been
used to reduce heat fever, resolve toxicity and treat
abscesses [43].
A study of 235 patients with lung cancer was
performed in Shandong Tumor Hospital, Jinan, China
from 1994 to 1997. Treatment was with a formulation
containing Codonopsis Tangshen Radix, Astragali
Radix, Atractylodis Macrocephalae Rhizoma,
Ophiopogonis Radix Recens, Angelicae Sinensis
Radix, Spatholobi Caulis, Houttuyniae Herba,
Fritillariae Thunbergii Bulbus, Glycyrrhizae Radix,
Rehmanniae Radix Praeparata, and Armeniacae
Semen [44]. Observations were made of the effects of
traditional Chinese herbs on chemotherapy sensitivity
and toxicity. Patients (139) of the study group were
treated with Chinese herbal medicine and combination
chemotherapy and 96 patients of the control group
were treated with combination chemotherapy alone.
The difference in efficacy rates between the study
group and the control group was significant with a P
value < 0. 05. The toxicities of chemotherapy on the
digestive tract, bone marrow and liver in study group
were less than those in the control group (P < 0. 01). Chinese herb medicine appears to not only prevent
side effects due to chemotherapy in lung cancer, but
also enhances the effects of chemotherapy.
Shen Yi capsule combined with chemotherapy can
enhance the therapeutic effect and reduce side effects
of chemotherapy in patients with NSCLC. Forty-one
patients with NSCLC were treated double-blindly with
chemotherapy plus Shen Yi capsule (Shen Yi group)
and chemotherapy plus placebo (placebo group). The
placebo group was compared to the Shen Yi group
with respect to response rate, time to progress (TTP),
median survival time (MST) and 12 year survival.
Shen Yi group : response rate 45.45 %, TTP 6 months,
13 months and MST12 year survival is 68.18 %. There
was a statistically significant difference between these
two groups (P < 0.05) with no adverse reactions found
in the two groups [45].
Fu Fang Ban Ao capsule is capable of increasing
the activity of NK cells which aid in killing cancer
cells [46]. It appears to be useful in the patients who
can not accept the chemotherapy. Patients (200) who
could not receive surgery in their stage of NSCLC
(stage III, IV) were treated with the Fu Fang Ban Ao
capsule [46].
Conclusions
Laboratory and clinical studies such as those
reported above provide an understanding of some
facts of CHM with regard to their effects and potential
mechanisms of action in the lung cancer. However,
it is important to point out that CHMs are most
commonly used as a formula, that is, a with several
herbal substances combined. TCM commonly uses
herbs not only to relieve symptoms, to stop disease
progression, and to restore healthy functioning of the
individual, but also to ameliorate or prevent adverse
side-effects linked to toxicity of individual drugs.
Detailed information concerning formulations, such
as the precise ingredients, amounts, and the methods
of preparation are critical for interpreting possible
benefits of these formulae in the management of lung
cancer.
Treatment of lung cancer is complex and appears
to be able to benefit from TCM. Therefore, the
pharmacological study of TCM medicines should
be encouraged. It is hoped that the search for new
medicinal compounds is likely to provide more potent
anticancer agents. The discovery of anticancer drugs
in Chinese botanicals should make important additions
to cancer therapy in the future.
References
[1] American Cancer Society. What Are the Key Statistics
for Lung Cancer? http://www.cancer.org 2005：
[10/18/2005].
[2] David S. Ettinger, Gerold Beple, James D. Cox, et al. Non-
Chinese herbal medicine in the treatment of lung cancer / Asian Journal of Traditional Medicines, 2008, 3 ( 1 )
small cell lung cancer. 2001 National Comprehensive
Cancer Network, Inc. Version 1. 2002：[2002, 08/08/01]
[3] Bruce E, Johnson, Athanassios A, Robert J, et al. 2002
Small cell lung cancer. National Comprehensive Cancer
Network, Inc. 2001: 1 [09/04/2001].
[4] Travis WD, Colby TV, Corrin B. Histological typing of
lung and pleural tumours. Berlin: Springer-Verlag. 1999.
[5] Simon G, Ginsberg RJ. Small-cell lung cancer. Chest Surg
Clin N Am.2001, 11: 165-88.
[6] Risberg T, Lund E, Wist E et al. Cancer patients use of
nonproven therapy: a 5 year follow up study. J Clin
Oncol. 1998, 16: 6-12.
[7] Schwartsmann G, Ratain MJ, Cragg GM et al. Anticancer
drug discovery and development throughout the world. J
Clin Oncol, 2002, 20: 47-59
[8] Bonham M, Arnold H, Montgomery M et al. Molecular
effects of the herbal compound PC-SPEC: identification
of activity pathways in prostate carcinoma. Cancer Res,
2002, 62: 3920-24.
[9] Liu JX, Pan ZR, Angela C. Lung cancer. http://: www.shennong.com 2006: [06/01/2006].
[10] Guo X Z, Song CL, Zhang CD. The regular of herbal
application for lung cancer Liaoning Journal of Traditional
Chinese Medicine. 2002, 29: 273
[11] Liu LF, Liang CH, Shiu LY, Lin WL, Lin CC, Kuo KW.
Action of solamargine on human lung cancer cellsenhancement of the susceptibility of cancer cells to TNFs.
FEBS Lett, 2004, 577(1-2): 67-74.
[12] Fleury F, Sukhanova A, Ianoul A, et al. Molecular
determinants of site-specific inhibition of human DNA
topoisomerase І by fagaronine and ethoxidine, relation to
DNA binding. J Biol Chem, 2000, 275: 3501-9
[13] Wang LK, Johnson RK. Inhibitions of topoisomerase І
function by nitidine and fagaronine. Chem Res Toxicol,
1993, 6: 813-8.
[14] Barthelmes HU, Niederberger E, Roth T EA. Lycobetaine
acts as a selective topoisomerase ІІ beta poison and
inhibits the growth of human tumour cells. Br J Cancer.
2001, 85: 1585-91.
[15]Barthomeuf C, Debiton E, Mshvildadze V. In vitro activity
of hederacolchiside et al. compared with other saponins
from Hedera colchica against proliferation of human
carcinoma and melanoma cells. Planta Med. 2002, 68:
672- 5.
[16] Kim YK, Yoon SK, et al. Cytotoxic triterpenes from stem
bark of physocarpus intermedius. Planta Med. 2000, 68:
392-6.
[17] Guinea MC, Parellada J, Lacaille-Dubois MA, et al.
Biologically active triterpene Saponins from Bupleurum
fruticosum.Plant med. 1994, 60: 163-7.
[18] Hu LY, Kuo PL, Liu CF, et al. The proliferative inhibition
and apoptotic mechanism of saikosaponind in human
non-small cell lung cancer A549 cells. Life Sci. 2004, 75:
1231-42.
[19] Cody V. Crystal and molecular structures of flavonoids.
Prog Clin Biol Res. 1988, 280: 29-44.
[20] Kraft C, Jenett-Siems K, Jakupovic J, et al. In vitro
antiplasmodial evaluation of medicinal plants from
Zimbabwe. Phyther Res, 2003, 17: 123-8.
[21] Wang LZ, He JB, Li JP. Expression of NF-kB and HIF1a induced by quercetin combination with DDPin lung
adenocarcinoma in mice. China journal of modern
medicine, 16(9): 1349-52.
[22] Tang W, Hemm I, Bertram B, Recent development of
antitumor agents from Chinese herbal medicines; Part
1. Low molecular compounds. Planta Med, 2003, 69:
97-108.
[23] Kim YS, Kim JS, Park SH, et al. Two cytotoxic
sesquiterpene lactones from the leaves of Xanthium
strumarium and their in vitro inhibitory activity on
farnesyltransferase. Planta Med, 2003, 69: 375-7.
[24] Adjei AA, Mauer A, Bruzek L, et al. Phase ІІ study of the
farnesyltransferase inhibitor R115777 in patients with
advanced non-small cell lung cancer. J Clin Oncol. 2003,
21: 1760-66.
[25] Menon GS, Kuchroo K, Dasgupta D. Interaction of
microtubules with active principles of Xanthium
strumarium. Physiol Chem Phys Med NMR, 2001, 33:
153-62.
[26] Xu LZ, Yang QY. The antitumor and anti-virus activity of
polysaccharopeptide (PSP). In advanced research in PSP,
Hong Kong: Hong Kong Association of Healthcare. 1999:
62-67.
[27] Kevin KW. Coriolus versicolor: a medicinal mushroom
with promising immunotherapeutic values. J Clin
Pharamcol, 2002, 42: 976-84.
[28] Kidd PM. The use of mushroom glucans and
proteoglycans in cancer treatment. Altern Med Rev, 2000,
5: 4-27.
[29] Chang HC, Huang YC HW. Antiproliferative and
chemopreventive effects of Adlay seed on lung cancer in
vitro and in vivo. J Agric Food Chem. 2003, 51: 3656-60.
[30] Cheng YL, Chang WL, Lee SC, Liu YG, Chen CJ, Lin
SZ EA. Acetone extract of Angelica sinensis inhibits
proliferation of human cancer cells via inducing cell cycle
arrest and apoptosis. Life Science, 2004, 75: 1579-94.
[31] Hoessel R, Leclerc S, Endicott JA, et al. Indirubin, the
active constituent of a Chinese antileukaemia medicine,
inhibits cyclin dependent kinases. Nat Cell Biol, 1999, 1:
60-7.
[32] Wangzhe Zhang, Jinfeng, Fu Guifang. Effect of Rhizoma
curcumate zedoariae and Herbra trifolii repentis on
10
Chinese herbal medicine in the treatment of lung cancer / Asian Journal of Traditional Medicines, 2008, 3 ( 1 )
apoptosis of human lung cancer cell line A549. Journal
of Capital University of Medical Sciences, 2006, 22(4):
304-5.
[33] Liu Haitao, Dai, Ximeng. The mechanism and antitumor
effect of Fu Zheng He Ji Decoction against L795 lung
cancer cell in mice. J Jiangsu TCM, 2004, 25(10): 56-7.
[34] Zhang ZY，Liu DS，Su XJ, et a1. Effect of YQHX
Mixture of CMM on expression of E-CD and invasion
of human lung cancer cell lines in vitro．Prae J Med and
Pharm, 2006, 133: 325-8.
[35] Lin L, Zhang QP, Yu I, et a1．Laboratory study on
antitumour effects of Sangenquliu Decoction for lewis
lung cancer．J of Zhejiang College of TCM, 1995, 19(1):
37-9.
[36] Pang DX, Guo Y．Laboratory study on Sansi Compo and
for transplanted carcinoma．Journal of Zhejiang College
of Traditional Chinese Medicine, 1993, 17(4): 34-5.
[37] Chang YF，Li J，Jin Y，et a1．Effects of QiJia Mixture
on cellular immune function in mouse Lewis lung
carcinoma．Acta Universitatis Medicinalis Anhui, 1999:
34(4): 266-7.
[38] Kaneko M，Kawakita T，Tauchi Y, et a1．Augmentation
of NK activiity after oral administration of a traditional
Chinese medicine, Xiao-chai-hu-tana (shosaiko-to).
Immunopharmacol Immunotoxicol 1994, 16(1): 41- 53．
[39] Stan Man , Angela Collingwood, Jennifer Eagleton et al.
Introduction to lung cancer and its treatments. http://:
www.shen-nong.com. 2006: [06/01/2006].
[40] Lu Haibo ,Jiang Hu, Jie Zhao Chang-hong Zhou Jianhua
Sui Hong,Bai Yuxian. Effect of Wei Mai Ning on
the quality of life and immume function of patients
with advancd lung cancer Chinese Journal of Clinical
Rehabilitation. 2006, 10 (23): 22-4.
[41] Liu JX, Pan MQ, Li YH, et al. Clinical study of Jin Fu
Kang oral Liquid for treating non-small cell cancer.
Tumor (Shanghai), 2001, 21(6): 463-5.
[42] Yan hong Y, DL Feng Ji, Yin Fuzai, et al. Observation
on efficacy of NP regimen combined with qingrejiedu
decoction in treatment of non-small cell lung cancer: a
report of 72 cases. Chin J Cancer Prev Treat. 2005, 12:
1785-7.
[43] Zhao XH, Jiang XY, Li Q, et al. Clinical observation on Ai
Di injection combined with chemotherapy in the treatment
of middle to advanced lung cancer. China J Cancer Prev
Treat, 2006, 13: 142-3.
[44] Xiao Jun, Zhang Yong, Yang Xinling, et al . Observation
o f t h e e ff e c t s o f t r a d i t i o n a l C h i n e s e h e r b s o n
chemotherapy sensitivity and toxicity of lung cancer:
Analysis of 235 cases. Shandong Tumor Hospital. 1999:
6(1): 35-7.
[45] Shi Meiqi, Feng Jifeng, Pan liangxi, Zhou Zhanfeng
Clinical observation of treating non-small-cell lung cancer
by chemotherapy and shenyi capsule. Chinese Clinical
Oncology, 2006, 113: 193-7.
[46] Jiang Hu, Zhang Taijun, Deng Xiaoling Clinical report
on the Fu Fang Ban’Ao capsule in the treatment of lung
cancer. J Practical Traditional Chinese Medicine, 2006,
223: 166-7.
11